BioCryst Pharmaceuticals | BCRX - Acreedores Comerciales

Precio De Mercado
9.56
Cambio Diario
-0.33 -3.34%
Mensual
12.60%
Anual
40.18%
Q2 Expectativa
9.30




Acreedores Comerciales Cambio Fecha
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Chugai Pharma JPY 127.25B 48.35B 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
DBV Technologies USD 39.82M 972K 2025-09
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novavax USD 24.58M 9.35M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12